Effect on Germline Mutation Rate in a High-Risk Chinese Breast Cancer Cohort after Compliance with The National Comprehensive Cancer Network (NCCN) 2023 v.1 Testing Criteria.

Cancers (Basel) · 2023 · PMC10177488 · PMID 37174101

Europe PMC DOI

hedged sentence

0.4760

closest p · 9.5× alpha

0.4760

boldest claim

The sentences

did not reach statistical significancep = 0.476not close (p > 0.1)

However, the difference in the percentage of the BRCA1/2 positive rate in these two groups (who met the NCCN testing guideline 2022 v.2 or 2023 v.1 criteria) did not reach statistical significance ( p = 0.476).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.